Category
144 releases
– Nine abstracts will be presented, including new data from Phase 4 research examining aesthetic treatment following medical weight loss, with a…
-- Vertical integration across med device product development services speeds time to market -- BOULDER, Colo., Nov. 3, 2026 — Boulder BioMed has…
Positive interim findings drive early trial conclusion; Hoth prepares to seek FDA alignment on a potential pivotal study for cancer treatment–related…
BonV Combines Agentic AI with Forward Deployed Engineers to Bring PhaseV's Vertical Suite of AI Modules into One Connected and Explainable,…
In this free webinar, learn how hybrid modeling can bring predictive decision-making earlier into upstream process development. The featured speakers…
New START site at the IRCCS Istituto Nazionale Tumori Regina Elena will expand access to cancer clinical trials for patients in a major European…
Stable organic revenue1 development driven by growth in Care Delivery and Care Enablement, offset by the expected decline in profit-neutral…
Award funds the final IND-enabling work needed prior to initiating Safi's first clinical trial CAMBRIDGE, Mass., Nov. 3, 2026 — Safi Biotherapeutics,…
PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that its Board of Directors has authorized a share repurchase program under which PTC may…
REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Stifel 2026 Healthcare Conference. Fireside Chat Details Date and Time:…
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced…
Presentation to highlight the initial safety profile and antitumor activity of PT0253 in advanced solid tumors, including in patients who received…
Power Knot LLC, the market leader for on site organic waste management solutions, announced today that BeLeaf Medical has installed an LCD-300…
LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers…
Health Canada Medical Device License makes VitaSmart® available to transplant centers across Canada U.S. FDA grants Breakthrough Device Designation…
Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds,…
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and…
Data presented at ESMO 2026 collectively supports the potential of darovasertib to become a foundational new therapy across the treatment journey of…
